期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 58, 期 1, 页码 517-521出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm500362j
关键词
-
Phosphoinositide 3-kinase gamma (PI3K gamma) is an attractive target to potentially treat a range of disease states. Herein, we describe the evolution of a reported phenylthiazole pan-PI3K inhibitor into a family of potent and selective benzothiazole inhibitors. Using X-ray crystallography, we discovered that compound 22 occupies a previously unreported hydrophobic binding cleft adjacent to the ATP binding site of PI3K gamma, and achieves its selectivity by exploiting natural sequence differences among PI3K isoforms in this region.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据